BioSpace News Archive

Brooks Automation, Inc. announced that company management will participate in the 22nd Annual Needham Growth Conference at the Lotte New York Palace hotel.

More than 330 AI Use Cases Will Contribute to Market Growth Across 28 Industries with the Strongest Enterprise AI Opportunity in Automotive, Consumer, Financial Services, Telecommunications and Retail Sectors

Kura Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, announced the appointment of Kirsten Flowers as Chief Commercial Officer.

Nephros, Inc. announced preliminary financial results for the fiscal year ended December 31, 2019.

Next-Generation Cardiac Myosin Inhibitor Advances In Clinical Trial Designed to Assess Effects Using Two-Week Dose Titration Schedule

Gregg Alton, the former interim CEO of Gilead Sciences, a company he served in many key roles during his more than 20 year tenure

The PROOF trial, a Phase 3 trial of infigratinib in first-line cholangiocarcinoma, is currently enrolling

Viking Therapeutics, Inc. announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at Biotech Showcase™ 2020, being held January 13-15, 2020 at the Hilton San Francisco Union Square in San Francisco.

Management will be hosting meetings at the LifeSci Advisors Corporate Access Event in San Francisco during the week

Global pharmaceutical company Mylan N.V. announced that Chairman Robert J. Coury, together with Upjohn’s Group President Michael Goettler and Mylan’s President Rajiv Malik, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on Wednesday, Jan. 15, 2020 at 8:30 a.m. PT / 11:30 a.m. ET.